Terms: = Brain cancer AND ATP2B3, PMCA3, 492, ENSG00000067842 AND Prognosis
8 results:
1. Mean global DNA methylation serves as independent prognostic marker in IDH-wildtype glioblastoma.
Eckhardt A; Drexler R; Schoof M; Struve N; Capper D; Jelgersma C; Onken J; Harter PN; Weber KJ; Divé I; Rothkamm K; Hoffer K; Klumpp L; Ganser K; Petersen C; Ricklefs F; Kriegs M; Schüller U
Neuro Oncol; 2024 Mar; 26(3):503-513. PubMed ID: 37818983
[TBL] [Abstract] [Full Text] [Related]
2. Exploring the Correlation of Abnormal CXCL9 Expression with Immune Infiltration in Glioma and Patient prognosis Based on TCGA and GTEx Databases.
Liao Y; Liu B; Jin C; Liao X; Zhang Z
J Mol Neurosci; 2022 Dec; 72(12):2413-2424. PubMed ID: 36449138
[TBL] [Abstract] [Full Text] [Related]
3. Exosomal PTEN as a Predictive Marker of Aggressive Gliomas.
Patnam S; Samal R; Koyyada R; Joshi P; Singh AD; Nagalla B; Soma MR; Sannareddy RR; Ippili K; Raju S; Boola RG; Lath R; Ranjan A; Ghosh S; Balamurugan M; Ray A; Manda SV
Neurol India; 2022; 70(1):215-222. PubMed ID: 35263886
[TBL] [Abstract] [Full Text] [Related]
4. Impact of histotypes on preferential organ-specific metastasis in triple-negative breast cancer.
Li Y; Su P; Wang Y; Zhang H; Liang Y; Zhang N; Song X; Li X; Li J; Yang Q
Cancer Med; 2020 Feb; 9(3):872-881. PubMed ID: 31814295
[TBL] [Abstract] [Full Text] [Related]
5. Postsurgical Approaches in Low-Grade Oligodendroglioma: Is Chemotherapy Alone Still an Option?
Franceschi E; Tosoni A; De Biase D; Lamberti G; Danieli D; Pizzolitto S; Zunarelli E; Visani M; Di Oto E; Mura A; Minichillo S; Scafati C; Asioli S; Paccapelo A; Bartolini S; Brandes AA
Oncologist; 2019 May; 24(5):664-670. PubMed ID: 30777895
[TBL] [Abstract] [Full Text] [Related]
6. Age-specific genome-wide association study in glioblastoma identifies increased proportion of 'lower grade glioma'-like features associated with younger age.
Ostrom QT; Kinnersley B; Armstrong G; Rice T; Chen Y; Wiencke JK; McCoy LS; Hansen HM; Amos CI; Bernstein JL; Claus EB; Eckel-Passow JE; Il'yasova D; Johansen C; Lachance DH; Lai RK; Merrell RT; Olson SH; Sadetzki S; Schildkraut JM; Shete S; Rubin JB; Andersson U; Rajaraman P; Chanock SJ; Linet MS; Wang Z; Yeager M; ; Houlston RS; Jenkins RB; Wrensch MR; Melin B; Bondy ML; Barnholtz-Sloan JS
Int J Cancer; 2018 Nov; 143(10):2359-2366. PubMed ID: 30152087
[TBL] [Abstract] [Full Text] [Related]
7. [prognosis in primary tumors of the central nervous system. A patient material from the Norwegian Radium Hospital 1960-94].
Lote K; Gundersen S; Hannisdal E; Hager B; Stenwig AE; Tverå K; Berg-Johnsen J; Skullerud K; Bakke SJ; Hirschberg H
Tidsskr Nor Laegeforen; 1996 Apr; 116(11):1320-4. PubMed ID: 8658412
[TBL] [Abstract] [Full Text] [Related]
8. N-myc amplification and neuronal differentiation in human primitive neuroectodermal tumors of the central nervous system.
Rouah E; Wilson DR; Armstrong DL; Darlington GJ
Cancer Res; 1989 Apr; 49(7):1797-801. PubMed ID: 2924321
[TBL] [Abstract] [Full Text] [Related]
